Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$2.15 – $3.53
23% from low
Exchange
OTC Link
OS
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | $2.54B | $2.65B | $2.43B | $2.23B | $2.75B | $2.96B | $4.62B | $3.84B |
| Cost of revenue | $2.13B | $2.09B | $2.06B | $1.89B | $2.18B | $2.37B | $3.24B | $3.09B |
| Gross profit | $409.2M | $566.4M | $372.0M | $342.1M | $575.0M | $589.0M | $1.38B | $754.4M |
| Gross margin | 16.1% | 21.3% | 15.3% | 15.4% | 20.9% | 19.9% | 29.9% | 19.6% |
| R&D | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 |
| Operating income | $124.9M | $287.9M | −$350.0M | −$87.4M | −$94.4M | $145.0M | $638.1M | $174.0M |
| EBITDA | $362.8M | $1.42B | $280.8M | $220.0M | $1.36B | $399.6M | $2.30B | $542.8M |
| Net income | $105.7M | $450.6M | −$646.8M | −$204.8M | −$69.0M | −$215.0M | $25.0M | $18.4M |
| Net margin | 4.2% | 17.0% | -26.6% | -9.2% | -2.5% | -7.3% | 0.5% | 0.5% |
| EPS (diluted) | 0.12 | 0.09 | -0.68 | -0.20 | -0.07 | -0.21 | 0.02 | 0.02 |
Annual figures · source: Financial Modeling Prep
| Year | Est. revenue | Est. EPS | EPS range | # Analysts |
|---|---|---|---|---|
| 2026 | $2.9B | $0.10 | $0.10–$0.11 | 1 |
| 2027 | $3.0B | $0.15 | $0.15–$0.16 | 1 |
| 2028 | $3.1B | $0.21 | $0.20–$0.22 | 1 |
| 2029 | $3.2B | $0.23 | $0.22–$0.24 | 1 |
Forward consensus · source: Financial Modeling Prep
IWG PLC ORD
No one on the platform currently holds IWGFF.
No tracked institution reports a position in IWGFF as of their last filing.
| Ex-date | Per share | Pay date |
|---|---|---|
| 2026-05-01 | $0.0093 | 2026-05-29 |
| 2025-09-19 | $0.0045 | 2025-10-17 |
| 2025-05-02 | $0.0090 | 2025-05-30 |
| 2024-09-06 | $0.0043 | 2024-10-04 |
| 2024-05-02 | $0.0100 | 2024-05-31 |
No one on the platform has traded IWGFF yet.
| +0.00% |
| $3.3B |
| — |
| HNLGFHang Lung Group Limited | $1.94 | +0.00% | $2.6B | — |
| HNLGYHang Lung Group Limited | $8.83 | +0.00% | $2.4B | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
Trading at 0.4× sales vs its 0.7× historical median P/S.
Fair value ≈ $4.04 · price $2.47 today
Fair-value line = the stock's median historical P/S × sales per share. Price below the orange line = cheap vs its own history; above = expensive. Not investment advice.